Capasso Planning Partners LLC Buys New Position in Oracle Corporation (NYSE:ORCL)

Capasso Planning Partners LLC purchased a new position in Oracle Corporation (NYSE:ORCL - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,035 shares of the enterprise software provider's stock, valued at approximately $285,000.

Other large investors have also recently made changes to their positions in the company. Cookson Peirce & Co. Inc. raised its position in Oracle by 4.4% in the fourth quarter. Cookson Peirce & Co. Inc. now owns 1,423 shares of the enterprise software provider's stock valued at $237,000 after purchasing an additional 60 shares during the period. Greenwood Gearhart Inc. increased its position in shares of Oracle by 1.2% during the 4th quarter. Greenwood Gearhart Inc. now owns 5,731 shares of the enterprise software provider's stock worth $955,000 after purchasing an additional 66 shares during the last quarter. WorthPointe LLC raised its holdings in Oracle by 4.0% in the 4th quarter. WorthPointe LLC now owns 1,734 shares of the enterprise software provider's stock valued at $289,000 after buying an additional 67 shares during the period. CORDA Investment Management LLC. lifted its position in Oracle by 0.9% in the fourth quarter. CORDA Investment Management LLC. now owns 7,966 shares of the enterprise software provider's stock valued at $1,328,000 after buying an additional 68 shares during the last quarter. Finally, Stage Harbor Financial LLC boosted its stake in Oracle by 5.0% during the fourth quarter. Stage Harbor Financial LLC now owns 1,433 shares of the enterprise software provider's stock worth $239,000 after buying an additional 68 shares during the period. 42.44% of the stock is currently owned by hedge funds and other institutional investors.

Oracle Stock Performance

Shares of ORCL stock traded up $2.56 during mid-day trading on Thursday, hitting $213.28. The stock had a trading volume of 10,517,186 shares, compared to its average volume of 9,915,599. The firm has a market cap of $599.07 billion, a PE ratio of 49.14, a PEG ratio of 3.23 and a beta of 1.32. The company's 50-day simple moving average is $165.09 and its 200-day simple moving average is $161.98. The company has a debt-to-equity ratio of 4.07, a current ratio of 0.75 and a quick ratio of 0.75. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $216.93.

Oracle (NYSE:ORCL - Get Free Report) last posted its quarterly earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.06. Oracle had a net margin of 21.68% and a return on equity of 87.34%. The firm had revenue of $15.90 billion during the quarter, compared to analysts' expectations of $15.58 billion. During the same period in the prior year, the company posted $1.63 earnings per share. The firm's revenue for the quarter was up 11.3% on a year-over-year basis. Sell-side analysts anticipate that Oracle Corporation will post 5 earnings per share for the current year.

Oracle Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 24th. Stockholders of record on Thursday, July 10th will be issued a $0.50 dividend. The ex-dividend date is Thursday, July 10th. This represents a $2.00 annualized dividend and a dividend yield of 0.94%. Oracle's dividend payout ratio is currently 46.08%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ORCL shares. Morgan Stanley reissued an "overweight" rating on shares of Oracle in a research note on Wednesday, June 18th. Cantor Fitzgerald decreased their price target on Oracle from $214.00 to $175.00 and set an "overweight" rating on the stock in a research note on Tuesday, March 11th. Monness Crespi & Hardt raised Oracle from a "sell" rating to a "neutral" rating in a research note on Monday, March 3rd. CIBC reiterated a "buy" rating on shares of Oracle in a report on Monday, June 9th. Finally, UBS Group set a $250.00 target price on Oracle and gave the stock a "buy" rating in a research note on Wednesday. Eleven research analysts have rated the stock with a hold rating, twenty-one have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $197.67.

Insider Activity

In related news, Director Leon E. Panetta sold 5,000 shares of the business's stock in a transaction dated Friday, April 11th. The shares were sold at an average price of $129.77, for a total transaction of $648,850.00. Following the sale, the director now owns 58,090 shares of the company's stock, valued at approximately $7,538,339.30. The trade was a 7.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Naomi O. Seligman sold 2,000 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $145.81, for a total value of $291,620.00. Following the completion of the sale, the director now owns 34,630 shares in the company, valued at approximately $5,049,400.30. This represents a 5.46% decrease in their position. The disclosure for this sale can be found here. Insiders sold 442,366 shares of company stock valued at $83,395,223 in the last three months. 42.20% of the stock is currently owned by company insiders.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.